Table 2 Clinical characteristics of the participants (n = 142)
Clinical characteristics | n (%) | |
|---|---|---|
Cancer diagnosis | Hematological malignancies | 94 (66.2) |
Wilms’tumor | 13 (9.2) | |
Rhabdomyosarcoma (RMS) | 9 (6.3) | |
Retinoblastoma | 8 (5.6) | |
Osteosarcoma | 7 (4.9) | |
Ewing Sarcoma | 6 (4.2) | |
Others* | 5 (3.5) | |
Time since diagnosis | < 6 months | 78(54.9) |
≥ 6–12 months | 34 (23.9) | |
≥ 12 months | 30 (21.1) | |
Chemotherapy status | Not started | 9 (6.3) |
On treatment | 128 (90.1) | |
Completed | 5 (3.5) | |
Treatment regimens | Chemotherapy alone | 110 (82.7) |
Chemotherapy + surgery | 20 (15.0) | |
Chemotherapy + radiation | 2 (1.5) | |
Chemotherapy + radiation + surgery | 1 (0.8) | |
Duration on treatment | < 6 months | 76 (57.1) |
≥ 6–12 months | 30 (22.6) | |
≥ 12–60 months | 27 (20.3) | |